Streetbeat News

Price Targets

ADBE

Mizuho analyst Gregg Moskowitz has reiterated a Buy rating on Adobe (NASDAQ:ADBE) and maintained a price target of $680. This reaffirms Mizuho's positive outlook on Adobe's stock.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:27 pm

MELI

Citigroup analyst Tobias Stingelin has maintained a Buy rating on MercadoLibre (NASDAQ:MELI) and adjusted the price target from $1990 to $1940.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:25 pm

MMM

Mizuho analyst Brett Linzey has maintained a Neutral rating on 3M (NYSE:MMM) and kept the price target at $105.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:25 pm

BALL

Citigroup analyst Anthony Pettinari reinstates coverage on Ball Corporation (NYSE:BALL) with a Neutral rating and sets a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:23 pm

CRVS

Mizuho analyst Graig Suvannavejh maintains a Neutral rating on Corvus Pharma (NASDAQ:CRVS) and keeps the price target at $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:22 pm

DNUT

Citigroup analyst Jon Tower has maintained a Neutral rating on Krispy Kreme (DNUT) and increased the price target from $14 to $19.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:20 pm

APLS

Mizuho analyst Graig Suvannavejh maintains a Neutral rating on Apellis Pharmaceuticals (NASDAQ:APLS) and keeps the price target at $60.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:18 pm

BL

Citigroup analyst Steven Enders has maintained a Neutral rating on BlackLine (NASDAQ:BL) and increased the price target from $57 to $66.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:16 pm

TSLA

RBC Capital analyst Tom Narayan has reiterated an Outperform rating on Tesla (NASDAQ:TSLA) and maintained a $298 price target.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:15 pm

RMD

Mizuho analyst Anthony Petrone reaffirmed a Buy rating on ResMed (NYSE:RMD) and maintained a $215 price target, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:15 pm